Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00361270 · ClinicalTrials.gov registry record · NA
Treatment of Veterans With Chronic Low Back Pain
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 161
- Enrollment target
NCT00361270: Completed NA study, sponsored by VA Office of Research and Development.
NCT00361270 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 161 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00361270, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 161 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effectiveness of hypnosis in the treatment of chronic low back pain.
Primary Outcome
The change score measures the difference between Pre-Treatment Brief Pain Inventory Pain Intensity Scale scores (Numerical Rating Scale (NRS): 0 no pain - 10 worst pain) and the 1-week Post--Treatment Brief Pain Inventory-Pain Intensity Scale scores for 4 items. Change is calculated as pre-treatment minus post treatment.
Interventions
- BEHAVIORAL Hyp-8
- BEHAVIORAL Hyp-2 w recordings
- BEHAVIORAL Hyp-8 w recordings
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2006-10-01 |
| Est. Completion | 2018-06-30 |
| Phase | NA |
What the finished NCT00361270 record still lists
NCT00361270 is an interventional study that assigns participants to a tested intervention. The registered 161 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 3 interventions - of which Hyp-8 is the first listed.
NCT00361270 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00361270 about?
NCT00361270 is a clinical study titled "Treatment of Veterans With Chronic Low Back Pain". The purpose of this study is to assess the effectiveness of hypnosis in the treatment of chronic low back pain.
What is the current status of trial NCT00361270?
This trial is currently completed. It is a NA study. The enrollment target is 161 participants. The study started on 2006-10-01. Estimated completion is 2018-06-30.
What interventions are being tested in trial NCT00361270?
The interventions under investigation include: Hyp-8 (BEHAVIORAL), Hyp-2 w recordings (BEHAVIORAL), Hyp-8 w recordings (BEHAVIORAL).
Who is sponsoring clinical trial NCT00361270?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00361270's enrollment target sits among peer trials
161 628th of 2000 higher than 1,373 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06391034 · 161 participants · Phase 2
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
- NCT06546670 · 161 participants · Phase 1
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
- NCT06616766 · 161 participants · Phase 1
A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946
- NCT06752356 · 161 participants · Phase 3
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI